Anything with AI in its name LOLVolume profile levels are telling me we can see a 30%+ run to demand zones.
Watch out for stop orders getting crushed on a possible gap downs before the pump. But this break could start a little run to my lines.
MDAI trade ideas
Spectral AI Inc. Takes Bold Step Towards Transforming Burn CareSpectral AI Inc. . (NASDAQ- NASDAQ:MDAI ), a Dallas-based predictive AI company, has commenced enrollment in a pivotal study to validate the effectiveness of their revolutionary DeepView AI® technology for burn injuries. This study marks a significant milestone on their journey towards seeking FDA marketing authorization for the burn indication in 2025.
With a focus on medical diagnostics for faster and more accurate treatment decisions in wound care, Spectral AI is at the forefront of innovation. Their DeepView AI® system, powered by proprietary imaging technology, aims to assess burn size and healing potential with unparalleled accuracy and speed. By predicting burn wound healing potential on the first day of injury, Spectral AI's technology has the potential to revolutionize burn care pathways and enable early treatment decisions.
The pivotal study will be conducted in burn centers and emergency departments across the United States, enrolling both adult and pediatric patients. Led by Dr. Jeffrey C. Carter, a highly experienced investigator, the study aims to deepen our understanding of how DeepView AI® can transform burn care while improving patient outcomes. This critical research will contribute to enhancing its preparedness for unforeseen emergencies, such as Burn Mass Casualty Incidents.
Spectral AI is utilizing significant government funding of $251 million since 2019 to validate DeepView for burn indication, as well as advancing other clinical indications like diabetic foot ulcers.
Key Beneficial Aspects of Spectral AI's DeepViewSpectral AI's DeepView® is an innovative mobile technology platform that brings advanced capabilities to the bedside and transforms wound healing diagnostics. DeepView® uses powerful AI algorithms and state-of-the-art multispectral imaging to assess wound healing potential more quickly and accurately, leading to improved patient care. On January 26, 2024, the NASDAQ:MDAI share price closed at $2.7100, with an increase of +0.7100, or 35.50%, showing a strong buying demand for its shares.
Spectral AI, Inc. (NASDAQ: NASDAQ:MDAI ) focuses on two specific areas of wound care: burns and diabetic foot ulcers. Applying the company's AI technology to these conditions will help doctors make more informed and accurate treatment decisions, resulting in more effective and efficient care for patients.
DeepView® fills a critical gap in the medical field with its ability to provide fast and reliable wound assessment. DeepView® provides healthcare professionals with advanced diagnostic tools, paving the way for proactive and personalized wound care solutions.
What is DeepView®?
DeepView® uses a multispectral camera to capture high-resolution images of wounds in just 2 seconds. This rapid, non-invasive process allows medical professionals to efficiently assess wounds at the bedside, eliminating the need for time-consuming and tedious procedures.
Advantages of multispectral imaging technology
The multispectral imaging technology used in DeepView® captures multiple wavelengths of light, allowing the extraction of unique tissue properties and structures that are invisible to the human eye. This comprehensive view of the wound serves as the basis for accurate and objective wound healing predictions.
Enhanced wound care management and strategies
One of the key benefits of DeepView® is its ability to identify wounds early and provide clear insight before treatment or other procedures start. Medical professionals can quickly and reliably assess the potential for wound healing, allowing them to optimize treatment plans and minimize complications.
